AU2836299A - Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins - Google Patents

Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins

Info

Publication number
AU2836299A
AU2836299A AU28362/99A AU2836299A AU2836299A AU 2836299 A AU2836299 A AU 2836299A AU 28362/99 A AU28362/99 A AU 28362/99A AU 2836299 A AU2836299 A AU 2836299A AU 2836299 A AU2836299 A AU 2836299A
Authority
AU
Australia
Prior art keywords
proteins
xeno
oestrogen
pcb
inter alia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28362/99A
Inventor
Werner E. G. Muller
Heinz C. Schroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2836299A publication Critical patent/AU2836299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)

Abstract

Method for monitoring natural and anthropogenic environmental chemicals in water or soil comprises assaying for protein 14-3-3 (Trends Biochem. Sci., 17, 498, 1992) as a biomarker in vertebrate or invertebrate indicator organisms exposed to the water or soil. An independent claim is also included for an enzyme-linked immunosorbent assay (ELISA) for determining the presence and amount of protein 14-3-3 in an extract or body fluid sample, comprising: (1) introducing the sample into a microtiter plate well coated with a 14-3-3-binding peptide, either directly or by interaction of the biotinylated peptide with a streptavidin coating, and (2) detecting and quantifying complex formation. ACTIVITY : None given. MECHANISM OF ACTION : None given.
AU28362/99A 1998-03-12 1999-03-10 Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins Abandoned AU2836299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19810721A DE19810721A1 (en) 1998-03-12 1998-03-12 Application of the 14-3-3 proteins as well as methods for the rapid determination of the 14-3-3 proteins as sensitive biomarkers for pollution and. a. with polychlorinated biphenyls (PCBs) and (xeno) estrogens
DE19810721 1998-03-12
PCT/EP1999/001545 WO1999046401A2 (en) 1998-03-12 1999-03-10 14-3-3 proteins used as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen

Publications (1)

Publication Number Publication Date
AU2836299A true AU2836299A (en) 1999-09-27

Family

ID=7860626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28362/99A Abandoned AU2836299A (en) 1998-03-12 1999-03-10 Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins

Country Status (5)

Country Link
EP (2) EP1536235A3 (en)
AT (1) ATE295898T1 (en)
AU (1) AU2836299A (en)
DE (3) DE19810721A1 (en)
WO (1) WO1999046401A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10131912A1 (en) * 2001-06-06 2002-12-19 Werner E G Mueller Determining isoforms of 14-3-3 family proteins, useful for early diagnosis of transmissible spongiform encephalopathies or toxicity testing
ES2407975T3 (en) 2006-05-09 2013-06-17 The University Of British Columbia Dissolved arthritis protein markers
JP5781764B2 (en) * 2007-11-27 2015-09-24 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 14-3-3η antibody and its use for the diagnosis and treatment of arthritis
DK2768851T3 (en) 2011-10-21 2017-09-18 Augurex Life Sciences Corp ANTIGENS DERIVED BY CITRULLINATED 14-3-3 AND APPLICATIONS THEREOF IN THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
KR101933692B1 (en) 2017-07-12 2018-12-28 동국대학교 산학협력단 Diagnostic kit comprising biomarkers for polychlorinated biphenyl 77 exposure diagnosis
RU2702852C1 (en) * 2018-07-20 2019-10-11 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Method for using marker proteins of saprobic groups of indicator organisms for assessing ecological state of an environment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948765A (en) * 1996-03-15 1999-09-07 Washington University Inhibition of intracellular signal transduction by 14-3-3-binding peptides
US5998149A (en) * 1996-04-05 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Method of detecting transmissible spongiform encephalopathies

Also Published As

Publication number Publication date
DE19980374D2 (en) 2000-09-28
WO1999046401A3 (en) 2000-03-09
EP0983377B1 (en) 2005-05-18
DE19810721A1 (en) 1999-10-14
ATE295898T1 (en) 2005-06-15
EP1536235A2 (en) 2005-06-01
WO1999046401A2 (en) 1999-09-16
DE59912059D1 (en) 2005-06-23
EP0983377A1 (en) 2000-03-08
EP1536235A3 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
ATE226729T1 (en) QUANTITATIVE IMMUNOCHROMATOGRAPHIC ASSAY
NZ306051A (en) Testing using electrochemiluminescence
BR9807435A (en) Immunoassay cassette for use in detecting an analyte in a sample of body fluid
ATE241139T1 (en) DEVICE FOR PERFORMING ONE OR MORE COMPETITIVE IMMUNOASSAYS
ATE245485T1 (en) DEVICE FOR DETERMINING ANALYTES IN SOLUTIONS
AU2003243558A1 (en) Test strip for detection of analyte and methods of use
ATE217190T1 (en) TEST AND REAGENTS FOR IDENTIFYING ANTIPROLIFERANT SUBSTANCES
Valentini et al. An electrochemical ELISA procedure for the screening of 17β-estradiol in urban waste waters
TW348216B (en) Method for the determination of urinary protein and creatinine
ATE101722T1 (en) QUALITATIVE ENZYME TEST FOR VISUAL EVALUATION.
BRPI0408255A (en) signal processing system and method
AU6667096A (en) Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody
GB0016814D0 (en) Improved dipstick assays (3)
AU673478B2 (en) Assay for the determination of protein in a biological sample
AU2836299A (en) Use of 14-3-3 proteins as sensitive biological markers for detecting pollution caused, inter alia, by polychlorinated biphenyl (pcb) and (xeno)oestrogen and method for quick determination of 14-3-3 proteins
AU2923401A (en) Methods for the quantitation of oxidized glutathione
DE59410041D1 (en) Test to determine sensitivity to activated protein C.
Slocum et al. Interference of biogenic amines with the measurement of proteins using bicinchoninic acid
CZ228898A3 (en) Method of determining state of hepatic function in individual, including receptor of hepatic graft
WO2003046202A3 (en) Assaying apparatus, kit, and method for lipids and associated enzymes
DE59907982D1 (en) Method for the detection of a protease activated in apoptosis
ATE360206T1 (en) METHOD FOR MEASURING THE TOTAL CONCENTRATION OF AN ANALYTE
ES2070834T3 (en) TEST CASE FOR THE DETERMINATION OF AN ANALYTE IN FECES.
WO2002014869A3 (en) Assay method and device for detecting the presence and concentration of analytes
EP1279961A3 (en) Non-isotopic method and kit for quantifying enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase